Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy

Pediatric Infectious Disease Journal

Volumn 32, Issue 1, 2013, Pages 39-44

  Kinabo, Grace D ^a   Sprengers, Mirte ^b   Msuya, Levina J ^a   Shayo, Aisa M ^a   Van Asten, Henri ^b   Dolmans, Wil M V ^b   Van Der Ven, Andre J A M ^b   Warris, Adilia ^b  

^a KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

anthropometry; highly active antiretroviral therapy; HIV; lipodystrophy; pediatrics

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AGE; ARM CIRCUMFERENCE; ARTICLE; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIPOATROPHY; LIPOHYPERTROPHY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STUNTING; TANZANIA;

ADOLESCENT; ANTHROPOMETRY; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; TANZANIA;

EID: 84871792120     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182755a34     Document Type: Article

References (25)

1. World Health Organization. Mother-to-child transmission of HIV. 2010. Available at: http://www.who.int/hiv/topics/mtct/en/index.html.
2. National Aids Control Program. Ministry of Health and Social Welfare. HIV/AIDS/STI Surveillance Report no 21. Dar-es-Salaam, Tanzania: Ministry of Health and Social Welfare; 2009.
3. Guaraldi G, Murri R, Orlando G, et al. Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev. 2008;10:152-161.
4. Jaquet D, Lévine M, Ortega-Rodriguez E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14:2123-2128.
5. Leonard EG, McComsey GA. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival. Infect Dis Clin North Am. 2005;19:713-729. (Pubitemid 41133537)
6. Amaya RA, Kozinetz CA, McMeans A, et al. Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21:405-410. (Pubitemid 34532934)
7. Aurpibul L, Puthanakit T, Lee B, et al. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther (Lond). 2007;12:1247-1254.
8. Beregszaszi M, Dollfus C, Levine M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr. 2005;40:161-168. (Pubitemid 41395714)
9. Desai N, Mullen P, Mathur M. Lipodystrophy in pediatric HIV. Indian J Pediatr. 2008;75:351-354. (Pubitemid 351713007)
10. Ene L, Goetghebuer T, Hainaut M, et al. Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study. Eur J Pediatr. 2007; 166:13-21. (Pubitemid 44900517)
11. Hartman K, Verweel G, de Groot R, et al. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Pediatr Infect Dis J. 2006;25:427-431.
12. Parakh A, Dubey AP, Kumar A, et al. Lipodystrophy and metabolic complications of highly active antiretroviral therapy. Indian J Pediatr. 2009;76:1017-1021.
13. Sánchez Torres AM, Munoz Muniz R, Madero R, et al. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children. Eur J Pediatr. 2005;164:271-276. (Pubitemid 40613041)
14. Sarni RO, Souza FI, Battistini TR, et al. Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed. J Pediatr (Rio J). 2009;85:329-334.
15. Taylor P, Worrell C, Steinberg SM, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics. 2004;114:e235-e242.
16. National AIDS Control Programme (NaCP). National Guidelines for management of HIV and AIDS, 2008. Government of Tanzania: National AIDS Control Programme (NaCP); 2009.
17. Lichtenstein KA, Ward DJ, Moorman AC, et al. HIV Outpatient Study Investigators. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389-1398. (Pubitemid 32662290)
18. Carr A, Emery S, Law M, et al. HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361:726-735. (Pubitemid 36293626)
19. Carr A, Law M; HIV Lipodystrophy Case Definition Study Group. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr. 2003;33:571-576. (Pubitemid 36975844)
20. Gerver WJM, de Bruin R. Paediatric Morphometrics: A Reference Manual. 2nd ed. Maastricht, The Netherlands: University Press; 2001.
21. Vigano A, Thorne C, Brambilla P, et al. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18:1443-1451. (Pubitemid 38925137)
22. Leonard EG, McComsey GA. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J. 2003;22:77-84. (Pubitemid 36091782)
23. Verweel G, van Rossum AM, Hartwig NG, et al. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002;109:E25.
24. Department of Nutrition for Health and Development. Software for assessing growth and development of the world's children. Geneva, Switzerland: World Health Organization; 2011.
25. McDowell MFK, Fryar C, Ogden C. Anthropometric reference data for children and adults: United States, 2003-2006. CBC Bulletin. 2008:10.